Skip to main content
Veterinary Medicines

EFFINOL

Authorised
  • Fipronil

Product identification

Medicine name:
EFFINOL, 2.5 mg/ml cutaneous spray, solution for cats and dogs
EFFINOL
Active substance:
  • Fipronil
Target species:
  • Dog
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    2.50
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous spray, solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • bottle of 500 ml
  • bottle of 250 ml
  • bottle of 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 65860/30-06-2020/K-0216006
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0214/001
Concerned member states:
  • Bulgaria
  • Estonia
  • Germany
  • Greece
  • Italy
  • Latvia
  • Portugal

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download
Greek (PDF)
Published on: 10/05/2022

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download

Labelling

English (PDF)
Published on: 22/12/2023
Download

eu-PUAR-esv0214001-dcp-effinol--2.5-mg-ml-cutaneous-spray--solution-for-cats-and-dogs-en.pdf

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."